{
    "organizations": [],
    "uuid": "0022b08f356fac63840cb89d8c2fd9654847e7e2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-icon-announces-deal-with-intel-all/brief-icon-announces-deal-with-intel-allowing-integration-of-the-intel-pharma-analytics-platform-for-clinical-trials-idUSFWN1RU0XC",
    "ord_in_thread": 0,
    "title": "BRIEF-ICON Announces Deal With Intel Allowing Integration Of The Intel Pharma Analytics Platform For Clinical Trials",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17, 2018 / 2:08 PM / Updated 29 minutes ago BRIEF-ICON Announces Deal With Intel Allowing Integration Of The Intel Pharma Analytics Platform For Clinical Trials Reuters Staff 1 Min Read \nApril 17 (Reuters) - ICON PLC: \n* ICON ANNOUNCES AGREEMENT WITH INTEL ALLOWING INTEGRATION OF THE INTELÂ® PHARMA ANALYTICS PLATFORM FOR CLINICAL TRIALS \n* ICON PLC - AGREED ON PRELIMINARY DEAL TERMS WITH INTEL TO ENABLE ICON TO OFFER INTEL PHARMA ANALYTICS PLATFORM FOR USE IN CLINICAL TRIALS Source text for Eikon: Further company coverage:",
    "published": "2018-04-17T17:05:00.000+03:00",
    "crawled": "2018-04-17T17:46:09.031+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "deal",
        "intel",
        "allowing",
        "integration",
        "intel",
        "pharma",
        "analytics",
        "platform",
        "clinical",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "icon",
        "plc",
        "icon",
        "announces",
        "agreement",
        "intel",
        "allowing",
        "integration",
        "pharma",
        "analytics",
        "platform",
        "clinical",
        "trial",
        "icon",
        "plc",
        "agreed",
        "preliminary",
        "deal",
        "term",
        "intel",
        "enable",
        "icon",
        "offer",
        "intel",
        "pharma",
        "analytics",
        "platform",
        "use",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}